PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?

被引:121
作者
Ahmed, W. [1 ]
Ziouzenkova, O. [1 ]
Brown, J. [1 ]
Devchand, P. [1 ]
Francis, S. [1 ]
Kadakia, M. [1 ]
Kanda, T. [1 ]
Orasanu, G. [1 ]
Sharlach, M. [1 ]
Zandbergen, F. [1 ]
Plutzky, J. [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA
关键词
PPARs; fatty acids; lipases; lipoproteins; thiazolidinediones; fibrates;
D O I
10.1111/j.1365-2796.2007.01825.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ahmed W, Ziouzenkova O, Brown J, Devchand P, Francis S, Kadakia M, Kanda T, Orasanu G, Sharlach M, Zandbergen F, Plutzky J (Brigham and Women's Hospital, Boston, MA; USA). PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? (Review) J Intern Med 2007; 262: 184-198. Peroxisome proliferator-activated receptors (PPARs) as ligand-activated nuclear receptors involved in the transcriptional regulation of lipid metabolism, energy balance, inflammation, and atherosclerosis are at the intersection of key pathways involved in the pathogenesis of diabetes and cardiovascular disease. Synthetic PPAR agonists like fibrates (PPAR-alpha) and thiazolidinediones (PPAR-gamma) are in therapeutic use to treat dyslipidaemia and diabetes. Despite strong encouraging in vitro, animal model, and human surrogate marker studies with these agents, recent prospective clinical cardiovascular trials have yielded mixed results, perhaps explained by concomitant drug use, study design, or a lack of efficacy of these agents on cardiovascular disease (independent of their current metabolic indications). The use of PPAR agents has also been limited by untoward effects. An alternative strategy to PPAR therapeutics is better understanding PPAR biology, the nature of natural PPAR agonists, and how these molecules are generated. Such insight might also provide valuable information about pathways that protect against the metabolic problems for which PPAR agents are currently indicated. This approach underscores the important distinction between the effects of synthetic PPAR agonists and the unequivocal biologic role of PPARs as key transcriptional regulators of metabolic and inflammatory pathways relevant to diabetes and atherosclerosis.
引用
收藏
页码:184 / 198
页数:15
相关论文
共 125 条
[81]   Identification characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPAR gamma 2 versus PPAR gamma 1 and activation with retinoid X receptor agonists and antagonists [J].
Mukherjee, R ;
Jow, L ;
Croston, GE ;
Paterniti, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) :8071-8076
[82]   Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) α knock-out mice -: Evidence for compensatory regulation by PPARδ [J].
Muoio, DM ;
MacLean, PS ;
Lang, DB ;
Li, S ;
Houmard, JA ;
Way, JM ;
Winegar, DA ;
Corton, JC ;
Dohm, GL ;
Kraus, WE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (29) :26089-26097
[83]   Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ [J].
Nagy, L ;
Tontonoz, P ;
Alvarez, JGA ;
Chen, HW ;
Evans, RM .
CELL, 1998, 93 (02) :229-240
[84]   Interactions of retinoid binding proteins and enzymes in retinoid metabolism [J].
Napoli, JL .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1999, 1440 (2-3) :139-162
[85]  
NATHAN DM, IN PRESS N ENGL J ME
[86]   Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes (vol 356, pg 2457, 2007) [J].
Nissen, Steven E. ;
Wolski, Kathy .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2457-2471
[87]   Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ) [J].
Peters, JM ;
Lee, SST ;
Li, W ;
Ward, JM ;
Gavrilova, O ;
Everett, C ;
Reitman, ML ;
Hudson, LD ;
Gonzalez, FJ .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (14) :5119-5128
[88]   Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice [J].
Peters, JM ;
Hennuyer, N ;
Staels, B ;
Fruchart, JC ;
Fievet, C ;
Gonzalez, FJ ;
Auwerx, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) :27307-27312
[89]   Inflammation in atherosclerosis and diabetes mellitus [J].
Plutzky, J .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2004, 5 (03) :255-259
[90]   The potential role,of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis [J].
Plutzky, J .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (4A) :34J-41J